05 / Archive
The full record of Cell-Ag reporting: news, science digests, columns and funding calls.
27 results
26 September 2026
Two precision fermentation companies are pursuing different routes to better economics and specialised nutrition, but partner results, commercial detail and independent evidence remain uneven across their claims.
26 September 2026
Ayana Bio and Zenfold are moving former Meati fermenters to India for plant cell work. The low purchase price raises harder questions about asset values, installation costs and viable manufacturing models.
25 September 2026
Bestzyme says its automated Jinan line can supply food manufacturers with fermentation-made brazzein at commercial scale. Regulatory progress offers access to the US, while production economics remain undisclosed.
25 September 2026
The European Commission wants more fermentation capacity and quicker routes from research to market. Alternative-protein advocates say its new strategy lacks the funding and regulatory access needed to deliver those aims.
24 September 2026 · Cultivated meat · Manufacturing · Funding · Bioprocess
A patent roundup highlights how Hanwha Solutions, Tufts University and IamFluidics are addressing culture-medium expense and cell-recovery losses, while leaving commercial-scale performance and patent outcomes unsettled.
24 September 2026 · Regulation
Friends & Family is adding cultivated Japanese quail broth toppers to its Singapore pet-food range, combining cell-grown meat with postbiotics and positioning the products against premium broths and supplements.
24 September 2026 · Cultivated meat · Regulation · Manufacturing
Food Standards Australia New Zealand is consulting on a cell-cultured duck ingredient application as consumer awareness remains limited and regulators prepare to assess feedback under newly established rules.
24 September 2026 · Fermentation · Manufacturing
Dyadic has brought an unidentified European biotechnology company into its dairy-protein program, extending a partnership-led commercialization strategy while leaving the products, economics and path to market largely undisclosed.
24 September 2026 · Cultivated meat · Regulation · Manufacturing
Aleph Farms has regulatory clearance for cultivated beef in Singapore and is preparing a restaurant debut, while partner facilities, production economics and undisclosed foodservice relationships shape its commercialization plan.
24 September 2026
UPSIDE Foods has left its proposed purchase of Believer Meats’ North Carolina factory. The withdrawal exposes separate asset sales, creditor claims and intellectual-property limits around the idle cultivated chicken plant.
24 September 2026 · Cultivated meat · Regulation · Manufacturing · Funding · Bioprocess
BeneMeat brought Czech meat-sector representatives inside its pilot facility to discuss cultivated-cell production, labeling and adoption, presenting incumbent processors as prospective customers rather than competitors.
24 September 2026 · Manufacturing · Funding · Bioprocess
Believer Meats’ Israeli trustee has lengthened the bidding period for the insolvent cultivated-meat company’s patents and production know-how as a separate sale advances for its North Carolina factory.
24 September 2026 · Fermentation · Manufacturing
Vegconomist reports that ADM and The EVERY Company will add US production for a precision-fermented egg-white protein, widening EVERY’s manufacturing footprint as demand strains its existing supply.
24 September 2026 · Fermentation · Manufacturing · Funding
C16 Biosciences has expanded its Palmless fermentation platform into food with a cocoa butter equivalent, as Saku Biosciences separately tackles strain-selection problems that can undermine commercial biomanufacturing.
24 September 2026 · Fermentation · Regulation · Manufacturing · Funding
Michroma and We Are Palta described how disciplined messaging, design and investor materials shaped a precision-fermentation fundraising campaign, while highlighting the cost of communicating complex food biotechnology.
24 September 2026
ProFuse Technology has tested new muscle-cell tools for cultivated meat and is taking its expertise into health research, as separate projects target media recycling and aquatic cell cultivation.
24 September 2026
TissenBioFarm has tasted coffee produced through plant cell culture as climate pressure raises questions about conventional supply. Its early work shows technical breadth, while leaving the commercial case largely open.
24 September 2026 · Cultivated meat · Manufacturing · Bioprocess
A South Korean university study examined a soil-fungus polysaccharide as a cultivated-beef culture aid, reporting benefits during cell expansion and muscle formation while leaving important commercial questions unanswered.
24 September 2026
Alternative protein companies face a harder funding market, weak consumer demand and costly production. Acquisitions offer one route forward, but buyers now expect evidence that products and processes can pay.
24 September 2026
A review finds that artificial intelligence can narrow research choices across alternative proteins, while uneven evidence, weak data standards and difficult scale-up economics limit its practical reach in cultivated meat.
24 September 2026
A bovine stem-cell protocol produces muscle alongside neural and vascular structures without serum. The work tests a simpler route to structured cultivated beef, while exposing substantial barriers to scale and food use.
24 September 2026 · Fermentation · Regulation · Manufacturing · Funding
A GFI APAC study examines why Chinese fermentation manufacturers are applying pharmaceutical and vitamin infrastructure to mycoprotein and precision fermentation, as policy backing meets oversupply and geopolitical risk.
24 September 2026
British food regulators have moved cellular agriculture into their nearest planning horizon. The decision clarifies where official attention will fall, while evidence from Singapore shows the harder commercial questions that follow approval.
24 September 2026
All G has recruited Malaysian life-sciences investor Xeraya Capital while universities and industry groups widen Asia-Pacific’s cellular agriculture network. The deal tests whether regional relationships can turn regulatory progress into sales.
06 / Methods
This section sets out how the material on this site is assembled, reviewed and published. It is placed here in full so that anything a reader or a regulator might want to know is available in one place.
Cell-Ag draws on a fixed list of regulators, peer-reviewed journals, research bodies and established trade press. Every published item carries its sources, and a source that cannot be resolved blocks publication. Nothing is cited that has not been retrieved and stored.
Automated tools are used to gather sources and to assemble drafts. They do not publish. Every draft is read, corrected and approved by the Chief Editor before it appears on the site, and editorial responsibility for everything published rests with him. Where a draft cannot be verified, it is not published.
Illustrations on this site are generated rather than photographed, and are presented as illustrations. They are never offered as documentary photographs of real facilities, people or events, and never depict data, micrographs or experimental results.
Corrections are run openly rather than adjusted quietly in the archive. Tips, corrections and complaints are triaged at the desk.
Our standards are set out in the editorial policy, and our interests are itemised under disclosure.